Prosight Management, LP Quant / Systematic

CIK: 0001617201 · Show all filings

Period: Q4 2020 (← Previous) (Next →)

Filing Date: Feb 12, 2021

Total Value ($000): $216,433 (100.0% shares, 0.0% debt)

Holdings (42)

ALEXION PHARMACEUTICALS INC 12.7%
Value ($000) $27,457 Shares 175,738 Est. Cost $116.07 Unrealized
ORGO ORGANOGENESIS HLDGS INC 7.0%
Value ($000) $15,237 Shares 2,023,441 Est. Cost $5.07 Unrealized -6.3%
PRTA PROTHENA CORP PLC 6.1%
Value ($000) $13,105 Shares 1,091,202 Est. Cost $11.93 Unrealized -0.8%
CUE CUE BIOPHARMA INC 5.2%
Value ($000) $11,341 Shares 906,569 Est. Cost $16.40 Unrealized -18.8%
ARENA PHARMACEUTICALS INC 5.2%
Value ($000) $11,194 Shares 145,700 Est. Cost $43.41 Unrealized
BMY BRISTOL-MYERS SQUIBB CO 4.8%
Value ($000) $10,483 Shares 169,000 Est. Cost $48.17 Unrealized +3.9%
BAX BAXTER INTL INC 4.5%
Value ($000) $9,715 Shares 121,075 Est. Cost $76.07 Unrealized -6.6%
EHC ENCOMPASS HEALTH CORP 4.4%
Value ($000) $9,451 Shares 114,300 Est. Cost $50.24 Unrealized +10.6%
CI CIGNA CORP NEW 4.0%
Value ($000) $8,622 Shares 41,418 Est. Cost $174.81 Unrealized +2.6%
CHANGE HEALTHCARE INC 3.6%
Value ($000) $7,843 Shares 420,514 Est. Cost $10.39 Unrealized
AUPH AURINIA PHARMACEUTICALS INC 3.3%
Value ($000) $7,036 Shares 508,715 Est. Cost $14.72 Unrealized -1.1%
VRTX VERTEX PHARMACEUTICALS INC 3.2%
Value ($000) $6,830 Shares 28,900 Est. Cost $229.44 Unrealized 0.0%
ALBIREO PHARMA INC 3.0%
Value ($000) $6,556 Shares 174,791 Est. Cost $29.64 Unrealized
ALEXION PHARMACEUTICALS INC 2.9%
Value ($000) $6,250 Shares 40,000 Est. Cost Unrealized
ALDX ALDEYRA THERAPEUTICS INC 2.9%
Value ($000) $6,232 Shares 908,488 Est. Cost $6.60 Unrealized +6.3%
MGTX MEIRAGTX HLDGS PLC 2.7%
Value ($000) $5,770 Shares 381,119 Est. Cost $20.76 Unrealized -31.9%
ZBH ZIMMER BIOMET HOLDINGS INC 2.5%
Value ($000) $5,470 Shares 35,501 Est. Cost $110.07 Unrealized +23.0%
CARA THERAPEUTICS INC 2.1%
Value ($000) $4,449 Shares 294,041 Est. Cost $14.99 Unrealized
METACRINE INC 2.0%
Value ($000) $4,428 Shares 563,303 Est. Cost $10.02 Unrealized
INOVALON HLDGS INC 1.9%
Value ($000) $4,195 Shares 230,877 Est. Cost $18.17 Unrealized
APTOSE BIOSCIENCES INC 1.7%
Value ($000) $3,613 Shares 824,795 Est. Cost $6.21 Unrealized
TWIST BIOSCIENCE CORP 1.6%
Value ($000) $3,532 Shares 25,000 Est. Cost Unrealized
MAGELLAN HEALTH INC 1.5%
Value ($000) $3,145 Shares 37,969 Est. Cost $82.83 Unrealized
ZOGENIX INC 1.4%
Value ($000) $2,989 Shares 149,522 Est. Cost $23.43 Unrealized
CNC CENTENE CORP DEL 1.1%
Value ($000) $2,401 Shares 40,000 Est. Cost $56.82 Unrealized +11.8%
PROTHENA CORP PLC 1.0%
Value ($000) $2,104 Shares 175,200 Est. Cost Unrealized
QURE UNIQURE NV 0.9%
Value ($000) $1,947 Shares 53,900 Est. Cost $56.70 Unrealized -25.6%
ADMA ADMA BIOLOGICS INC 0.8%
Value ($000) $1,722 Shares 883,214 Est. Cost $2.91 Unrealized -27.7%
VERACYTE INC 0.8%
Value ($000) $1,713 Shares 35,000 Est. Cost Unrealized
REATA PHARMACEUTICALS INC 0.7%
Value ($000) $1,497 Shares 12,112 Est. Cost $77.92 Unrealized
SPDR SER TR 0.7%
Value ($000) $1,408 Shares 10,000 Est. Cost Unrealized
ARENA PHARMACEUTICALS INC 0.6%
Value ($000) $1,383 Shares 18,000 Est. Cost Unrealized
IMTX IMMATICS N.V 0.5%
Value ($000) $1,133 Shares 104,999 Est. Cost $10.53 Unrealized +0.1%
PRQR PROQR THRAPEUTICS N V 0.5%
Value ($000) $1,071 Shares 255,000 Est. Cost $4.22 Unrealized 0.0%
MIRM MIRUM PHARMACEUTICALS INC 0.5%
Value ($000) $1,052 Shares 60,250 Est. Cost $19.66 Unrealized 0.0%
MAGENTA THERAPEUTICS INC 0.5%
Value ($000) $985 Shares 125,654 Est. Cost $7.29 Unrealized
ARK ETF TR 0.4%
Value ($000) $933 Shares 10,000 Est. Cost Unrealized
BEAM THERAPEUTICS INC 0.4%
Value ($000) $816 Shares 10,000 Est. Cost Unrealized
AKUMIN INC 0.3%
Value ($000) $675 Shares 224,273 Est. Cost $3.01 Unrealized
LHC GROUP INC 0.3%
Value ($000) $586 Shares 2,746 Est. Cost $213.40 Unrealized
ACIU AC IMMUNE SA 0.0%
Value ($000) $46 Shares 8,942 Est. Cost $5.96 Unrealized -14.3%
MRNA MODERNA INC 0.0%
Value ($000) $18 Shares 174 Est. Cost $101.17 Unrealized 0.0%